PATENT CLAIM ANALYSIS

Application Number: 16138224
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-06
Patent Classification: ["424", "185100"]

Abstract:
The present disclosure provides recombinant polypeptides, nucleic acids encoding the recombinant polypeptides and methods for using these polypeptides and/or nucleic acids in enhancing or inducing an immune response in a subject in need thereof. The present disclosure also provides methods of treating a cell proliferative disorder, such as cancer, by administering the disclosed polypeptides and/or nucleic acids to a subject in need thereof.

Claim (Index 26):
The method of  claim 11 , wherein the recombinant polypeptide comprises the amino acid sequence of SEQ ID NO: 9.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 97.0
- Lexical Diversity: 1.61905
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16138204', '16138219', '15854906', '16138212', '11332037']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8392010054550546
- 35 USC 102 Novelty (BERT): 0.6387336732324992
- Combined Prediction Score: 0.819154272232799
- Mean Citation Score: 602.9591839999998
- Max Citation Score: 709.03534
- Similarity Product: 544.9113032603693

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test